Metoda mnożnikowa – opiera się na porównaniu mnożników firm z branży, w której działa wyceniana spółka (np.
EV/EBITDA, P/E, P/BV). Metoda ta bardzo dobrze odzwierciedla bieżący stan rynku, wymaga mniejszej liczby założeń
oraz jest prostsza w zastosowaniu.
Do jej wad można zaliczyć dużą podatność wyceny na zmienność cen porównywanych spółek, subiektywny dobór
porównywalnych firm oraz uproszczenie obrazu spółki prowadzące do pominięcia bardzo istotnych parametrów (np.
przewaga konkurencyjna, tempo wzrostu, poziom rentowności, strukturę zadłużenia).
|
EV/EBITDA TTM |
P/E TTM |
P/B TTM |
| Mediana dla branży |
9.0
|
18.5
|
1.1
|
| Paragon Care Limited |
5.1
|
19.4
|
1.2
|
| Mediana / Paragon Care Limited |
1.8
|
1.0
|
1.0
|
Pozostałe spółki z branży Medical - Distribution
| Nazwa firmy |
Symbol |
Kapitalizacja (mln $) |
EV/EBITDA |
P/E |
P/B |
Giełda |
| Medlive Technology Co., Ltd. |
2192.HK |
1,412 |
115.0 |
32.1 |
2.1 |
HKSE |
| Patterson Companies, Inc. |
PDCO |
2,772 |
7.2 |
19.9 |
2.8 |
NASDAQ Global Select |
| Prestige Consumer Healthcare Inc. |
PBH |
3,228 |
6.4 |
15.1 |
1.7 |
New York Stock Exchange |
| McKesson Corporation |
MCK |
84,208 |
15.4 |
26.6 |
-42.7 |
New York Stock Exchange |
| EBOS Group Limited |
EBO.NZ |
4,918 |
9.0 |
23.8 |
2.9 |
NZSE |
| Owens & Minor, Inc. |
OMI |
441 |
-0.1 |
-0.4 |
-1.6 |
New York Stock Exchange |
| Profarma Distribuidora de Produtos Farmacêuticos S.A. |
PFRM3.SA |
181 |
-0.4 |
7.9 |
0.7 |
São Paulo |
| Cencora |
0HF3.L |
57,231 |
11.3 |
29.9 |
28.7 |
London Stock Exchange |
| Cencora |
COR |
57,049 |
11.3 |
29.9 |
28.7 |
New York Stock Exchange |
| PT Soho Global Health Tbk |
SOHO.JK |
554 |
13.3 |
17.0 |
3.3 |
Jakarta Stock Exchange |
| IVD Medical Holding Limited |
1931.HK |
1,804 |
29.6 |
45.9 |
3.2 |
HKSE |
| MediPal Holdings Corporation |
7459.T |
3,641 |
8.3 |
13.3 |
0.9 |
Tokyo |
| China Meheco Group Co., Ltd. |
600056.SS |
2,246 |
8.7 |
29.2 |
1.4 |
Shanghai |
| Cardinal Health, Inc. |
CAH |
35,793 |
10.8 |
22.9 |
-13.6 |
New York Stock Exchange |
| Liaoning Cheng Da Co., Ltd. |
600739.SS |
2,569 |
11.9 |
40.4 |
0.6 |
Shanghai |
| Uniphar plc |
UPR.L |
1,211 |
7.1 |
16.9 |
2.7 |
London Stock Exchange |
| Paragon Care Limited |
PGC.AX |
421 |
5.1 |
19.4 |
1.2 |
Australian Securities Exchange |
| ClouDr Group Limited |
9955.HK |
124 |
-9.6 |
-6.9 |
0.5 |
HKSE |
| China National Accord Medicines Corporation Ltd. |
000028.SZ |
1,851 |
19.6 |
24.7 |
0.8 |
Shenzhen |
| Alfresa Holdings Corporation |
2784.T |
2,741 |
11.5 |
14.9 |
0.8 |
Tokyo |
| AS ONE Corporation |
7476.T |
1,263 |
18.6 |
22.0 |
2.7 |
Tokyo |
| EBOS Group Limited |
EBO.AX |
4,934 |
11.6 |
29.4 |
2.9 |
Australian Securities Exchange |
| Yamashita Health Care Holdings,Inc. |
9265.T |
55 |
10.9 |
13.5 |
0.9 |
Tokyo |
| Galenica AG |
GALE.SW |
5,183 |
13.4 |
22.8 |
2.7 |
Swiss Exchange |
| OLBA HEALTHCARE HOLDINGS, Inc. |
2689.T |
82 |
4.6 |
9.1 |
1.0 |
Tokyo |
| Ame Company For Medical Supplies |
9527.SR |
232 |
17.3 |
19.1 |
5.5 |
Saudi |
| Bastide Le Confort Médical SA |
BLC.PA |
246 |
-1.6 |
120.0 |
2.7 |
Paris |
| Medios AG |
ILM1.DE |
425 |
3.1 |
24.3 |
0.7 |
Frankfurt Stock Exchange |
| Sinopharm Group Co. Ltd. |
1099.HK |
7,793 |
1.7 |
7.9 |
0.7 |
HKSE |
| China National Accord Medicines Corporation Ltd. |
200028.SZ |
1,876 |
19.9 |
12.1 |
0.4 |
Shenzhen |
| Healthlead Public Company Limited |
HL.BK |
61 |
9.5 |
24.8 |
1.9 |
Thailand |
| PT Enseval Putera Megatrading Tbk. |
EPMT.JK |
384 |
5.4 |
8.1 |
0.8 |
Jakarta Stock Exchange |
| Uniphar plc |
UPR.IR |
1,091 |
17.2 |
72.3 |
2.8 |
Irish |
| Realcan Pharmaceutical Group Co., Ltd. |
002589.SZ |
533 |
5.9 |
228.9 |
0.8 |
Shenzhen |
| Great Elm Group, Inc. |
GEG |
60 |
11.2 |
-40.9 |
1.0 |
NASDAQ Global Select |
| Vital KSK Holdings, Inc. |
3151.T |
420 |
6.9 |
8.4 |
0.6 |
Tokyo |
| Arjo AB (publ) |
ARJO-B.ST |
945 |
4.1 |
20.8 |
1.2 |
Stockholm Stock Exchange |
| Shanghai Pharmaceuticals Holding Co., Ltd |
601607.SS |
8,864 |
4.6 |
16.0 |
1.0 |
Shanghai |
| Charmacy Pharmaceutical Co., Ltd. |
2289.HK |
81 |
-3.3 |
10.8 |
0.9 |
HKSE |
| Hanmi Science Co., Ltd. |
008930.KS |
2,059 |
40.4 |
54.1 |
3.3 |
KSE |
| Navamedic ASA |
NAVA.OL |
55 |
9.8 |
322.1 |
1.7 |
Oslo Stock Exchange |
| Suzuken Co., Ltd. |
9987.T |
2,745 |
11.1 |
11.9 |
1.0 |
Tokyo |
| Sigma Healthcare Limited |
SIG.AX |
21,539 |
781.3 |
-323.1 |
5.3 |
Australian Securities Exchange |
| Shenzhen Glory Medical Co.,Ltd. |
002551.SZ |
521 |
46.2 |
152.1 |
1.3 |
Shenzhen |
| Shanghai Pharmaceuticals Holding Co., Ltd |
2607.HK |
8,924 |
5.3 |
9.9 |
0.6 |
HKSE |
| DocMorris AG |
0RRB.L |
458 |
-3.5 |
-0.9 |
0.3 |
London Stock Exchange |
| PT Kimia Farma (Persero) Tbk |
KAEF.JK |
183 |
29.0 |
-3.5 |
1.3 |
Jakarta Stock Exchange |
| WIN-Partners Co., Ltd. |
3183.T |
252 |
17.6 |
18.9 |
1.6 |
Tokyo |
| Guangxi LiuYao Group Co., Ltd |
603368.SS |
1,008 |
5.7 |
8.8 |
0.9 |
Shanghai |
| Henry Schein, Inc. |
HSIC |
8,248 |
5.2 |
21.3 |
2.4 |
NASDAQ Global Select |
| CHC Healthcare Group |
4164.TW |
292 |
5.2 |
45.2 |
1.1 |
Taiwan |